Information campaigns to increase vaccine uptake

How to cite

Ashworth, Madison; Finnoff, David; Cherry, Todd; Newbold, Stephen; Thunstrom, Linda. 2020. "Information campaigns to increase vaccine uptake." AEA RCT Registry. AEARCTR-0006885. https://doi.org/10.1257/rct.6885-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Madison Ashworth* , David Finnoff , Todd Cherry , Stephen Newbold , Linda Thunstrom

* Primary investigator

Registry ID
AEARCTR-0006885
DOI
https://doi.org/10.1257/rct.6885-1.0
First registered
Last updated
Status
In development
Trial dates
2020-12-11 – 2021-01-01
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/6885

Abstract

The goal of this study is to determine how information campaigns that explain different benefits of widespread vaccination against COVID-19 affect vaccine uptake. We will conduct a survey experiment where participants will be exposed to 1 of 9 different information treatments including: a no information, control treatment, information explaining the economic benefits of taking the COVID-19 vaccine, the public health benefits of widespread vaccination against COVID-19, the private health benefits of vaccinating against COVID-19, and combinations of private health benefit, public health benefit, and economic benefit messages, and the vaccine trial process.

Intervention

We will conduct a survey experiment where participants will be exposed to 1 of 9 different information treatments including: a no information, control treatment, information explaining the economic benefits of taking the COVID-19 vaccine, the public health benefits of widespread vaccination against COVID-19, the private health benefits of vaccinating against COVID-19, and combinations of private health benefit, public health benefit, and economic benefit messages, and the vaccine trial process.

Experimental design

Participants will be randomized into 1 of 9 different information treatments where they will be informed of the private health benefits of vaccination, the public health benefits of vaccination, the economic benefits of vaccination, a combination of private, public and economic benefits, or the vaccine trial process. Participants will then be asked about their willingness to take a COVID-19 vaccine. In the second part of the survey, participants will be asked about how they have been affected most by the pandemic, what they worry about most, the extent they are complying with social distancing and mask wearing, and how disruptive the pandemic has been in terms of health and employment.

Design details

Randomization method
by a computer
Randomization unit
Individual
Clusters
0
Observations
3000
Arms
333
Primary outcomes
The proportion of the population that will take the vaccine when it first becomes available.

Cited by

No citation data available for this registration yet.

Keywords